[CITATION][C] A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation. EMBO Mol Med. 2018

M Castroviejo-Bermejo, C Cruz, A Llop-Guevara… - Article e9172 View in …, 2018